Sign up to be part of ‘world-first’ global health study into Parkinson’s disease
Author: Parkinson's Life editorsPublished: 18 February 2016
Prep: Cook: Serves:
A pioneering project invites people with Parkinson’s to take part in a ‘world-first’ global study and help change healthcare – with just their smartphones
Do you own a smartphone? Then you too can become a citizen scientist and help improve our insight and understanding of Parkinson’s disease in a new innovative global study.
The ‘100 for Parkinson’s’ global study is a pioneering project that promises to gather data about all aspects of living with Parkinson’s, including sleep quality, mood, exercise, diet and stress levels. According to the organisers, it is a ‘world-first, ethics-approved, people-centred’ project.
Using a smartphone app specially developed for the study by uMotif, participants will track 10 important health aspects over a period of 100 days.
This data will provide key information for a team of academic researchers from leading Parkinson’s charities to learn more about how different health factors affect the disease, and could lead to new discoveries about the condition. For example, we may discover how factors such as the time of day that medications are taken affect a patient’s reflexes.
How to take part
Visit www.100forparkinsons.com, download the uMotif app from the App Store or Google Play and enter the code ‘100fp’ to unlock the study.
You must be aged 18 or over, own a smartphone or tablet and be willing to track your health for 100 days and donate your data.
Parkinson’s UK urges British government to change stance on disability assessments
Parkinson’s UK urges government to change disability allowance
4 days ago
Could a sea sponge support the search for Parkinson’s disease treatments?
How could a molecule in a sea sponge help treat Parkinson’s and similar conditions? Researchers at the University of California, Los Angeles (UCLA), in the US, recently explored this question. Their findings were published in the journal ‘Science’. The team examined a molecule known as lissodendoric acid A, which appears to counteract other molecules that damage DNA, proteins and whole cells – and was recently discovered in a sea sponge. The research team used an oft-neglected compound called a cyclic allene to control a step in the chain of chemical reactions, which enabled them to create a version of the molecule in a lab. Scientists believe that the ability to synthetically produce lissodendoric acid A will help them assess whether it can inform future therapies for conditions like Parkinson’s. UCLA’s Professor Neil Garg, the corresponding author of the study, said: “We hope others will also be able to use cyclic…
Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease
Regular exercise is a common therapeutic strategy for people with Parkinson’s. Now, a study from New Zealand has suggested that daily physical activity might even delay the onset of this condition. Published in ‘The Physiological Society’, the study focused on a protein called brain-derived neurotrophic factor (BDNF) – which has previously been shown to boost cognitive performance. The researchers assessed the impact of fasting and physical activity on BDNF production in 12 people aged 18 to 56. The tests involved fasting and completing exercises of varying intensity, such as cycling for six minutes, as well as combinations of both fasting and physical activity. The results showed that brief, intense exercise was the best option for increasing the production of BDNF – with the protein increasing by a factor of four to five times compared to light exercise or fasting. Because BDNF can protect the brain from cognitive decline, the findings could…
Machine learning may help predict risk of freezing of gait in Parkinson’s disease
Difficulty taking steps forward, often referred to as the freezing of gait (FOG), is a common symptom experienced by people with Parkinson’s and one that can be difficult to predict. China-based researchers suggest that machine learning – artificial intelligence (AI) that uses algorithms to analyse data – could help predict the risk of freezing of gait developing in the early stages of the condition. Their study, published in ‘npj Parkinson’s Disease’, gave laboratory and clinical data to a machine learning model brain. This information was collected from 158 adults with untreated early-stage Parkinson’s and 73 healthy adults over a five-year period. They found that the risk of FOG could be predicted with an accuracy rate of up to 78%. The study authors suggested that machine learning methods “have the potential to help predict future FOG in patients with early Parkinson’s at an individual level”.